Scripps Health

Futó vizsgálatok

• Toboroz

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  NCT07221500· 2. fázis· Nurix Therapeutics, Inc.· Forrás

• Toboroz

  Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

  NCT07065721· San Diego State University· Forrás

• Toboroz

  A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

  NCT06764940· 2. fázis· Biostar Pharma, Inc.· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  NCT06790693· 3. fázis· Hoffmann-La Roche· Forrás

• Meghívásos bevonás

  Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

  NCT06560021· Abramson Cancer Center at Penn Medicine· Forrás

• Toboroz

  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  NCT06479135· 3. fázis· Kartos Therapeutics, Inc.· Forrás

• Toboroz

  A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  NCT06112418· Cleerly, Inc.· Forrás

• Toboroz

  Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  NCT06293898· 1. fázis· SystImmune Inc.· Forrás

• Meghívásos bevonás

  Phase 1/2a Study of ANPD001 in Parkinson Disease

  NCT06344026· 1. fázis· Aspen Neuroscience· Forrás

• Fut, nem toboroz

  Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)

  NCT06181240· Bolt Medical· Forrás

• Toboroz

  The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  NCT05836987· 3. fázis· Johns Hopkins University· Forrás

• Fut, nem toboroz

  REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

  NCT05611918· Johns Hopkins University· Forrás

• Fut, nem toboroz

  ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

  NCT05686317· Edwards Lifesciences· Forrás

• Fut, nem toboroz

  An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

  NCT05565599· Jaguar LAA, Inc.· Forrás

• Toboroz

  HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

  NCT06425848· University of Kansas Medical Center· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

  NCT05306340· 3. fázis· Genentech, Inc.· Forrás

• Fut, nem toboroz

  A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  NCT05100862· 3. fázis· BeOne Medicines· Forrás

• Toboroz

  Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

  NCT04592445· Axon Therapies, Inc.· Forrás

• Fut, nem toboroz

  Amplatzer Amulet LAAO vs. NOAC

  NCT04226547· Abbott Medical Devices· Forrás

• Fut, nem toboroz

  ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement

  NCT03973372· University of Texas Southwestern Medical Center· Forrás

• Fut, nem toboroz

  Reducing Lung CongestIon Symptoms in Advanced Heart Failure

  NCT03499236· V-Wave Ltd· Forrás

• Toboroz

  The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  NCT03142152· Cardiac Dimensions, Inc.· Forrás

• Fut, nem toboroz

  LEADERS FREE II: BioFreedom™ Pivotal Study

  NCT02843633· Biosensors Europe SA· Forrás

• Fut, nem toboroz

  Genomic Investigation of Cardiovascular Diseases

  NCT00722748· Scripps Translational Science Institute· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Szívelégtelenség3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Áttétes emlőrák1 toboroz
• Brain metastases1 toboroz
• Colitis ulcerosa1 toboroz
• Crohn-betegség1 toboroz
• Fej-nyaki daganatok1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Parkinson-kór1 toboroz
• Petefészekrák1 toboroz
• Pitvarfibrilláció1 toboroz
• Stroke (szélütés)1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Leállították

  A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma

  NCT05556616· 1. fázis· Teva Branded Pharmaceutical Products R&D LLC· Forrás

• Leállították

  CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

  NCT05207722· 1/2. fázis· Celularity Incorporated· Forrás

• Lezárult

  AMPLATZER™ Amulet™ LAA Occluder Trial

  NCT02879448· Abbott Medical Devices· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Eosinophilic oesophagitis3 munka · 0 vizsgálat